- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Shuffling continues at Del Global
Leonard A. Trugman is out as CEO, president, and chair of the board at Del Global Technologies. Financial troubles led to the firing last month of the president and CFO of its Medical Systems Group (SCAN 2/14/01). Trugman “agreed to
Leonard A. Trugman is out as CEO, president, and chair of the board at Del Global Technologies. Financial troubles led to the firing last month of the president and CFO of its Medical Systems Group (SCAN 2/14/01). Trugman “agreed to resign” his position as an officer and director, according to the company, “to pursue other opportunities.” Meanwhile the company’s board elected Samuel E. Park as acting president and CEO, Thomas V. Gilboy as CFO, and Carole Murphy as corporate controller. Roger Winston was elected chair of the board. (George Solomon also resigned from the board, although his leaving is “unrelated to the foregoing,” according to the company.)
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
